214 related articles for article (PubMed ID: 37595566)
1. Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin.
Ruf B; Bruhns M; Babaei S; Kedei N; Ma L; Revsine M; Benmebarek MR; Ma C; Heinrich B; Subramanyam V; Qi J; Wabitsch S; Green BL; Bauer KC; Myojin Y; Greten LT; McCallen JD; Huang P; Trehan R; Wang X; Nur A; Murphy Soika DQ; Pouzolles M; Evans CN; Chari R; Kleiner DE; Telford W; Dadkhah K; Ruchinskas A; Stovroff MK; Kang J; Oza K; Ruchirawat M; Kroemer A; Wang XW; Claassen M; Korangy F; Greten TF
Cell; 2023 Aug; 186(17):3686-3705.e32. PubMed ID: 37595566
[TBL] [Abstract][Full Text] [Related]
2. Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment.
Shaler CR; Tun-Abraham ME; Skaro AI; Khazaie K; Corbett AJ; Mele T; Hernandez-Alejandro R; Haeryfar SMM
Cancer Immunol Immunother; 2017 Dec; 66(12):1563-1575. PubMed ID: 28798979
[TBL] [Abstract][Full Text] [Related]
3. Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma.
Duan M; Goswami S; Shi JY; Wu LJ; Wang XY; Ma JQ; Zhang Z; Shi Y; Ma LJ; Zhang S; Xi RB; Cao Y; Zhou J; Fan J; Zhang XM; Gao Q
Clin Cancer Res; 2019 Jun; 25(11):3304-3316. PubMed ID: 30723143
[TBL] [Abstract][Full Text] [Related]
4. Regulatory mucosa-associated invariant T cells controlled by β1 adrenergic receptor signaling contribute to hepatocellular carcinoma progression.
Fu S; Liu M; Zhu C; Zhang H; Zhao C; Xie Y; Chen G; Sheng D; Pan J; He Z; Dai Y; Gao Y; Li X; Chen L; Qian Y; Jin T; Sun C; Tian Z; Wang H; Bai L
Hepatology; 2023 Jul; 78(1):72-87. PubMed ID: 36626624
[TBL] [Abstract][Full Text] [Related]
5. Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma.
Park DJ; Sung PS; Lee GW; Cho S; Kim SM; Kang BY; Hur W; Yang H; Lee SK; Lee SH; Jung ES; Seo CH; Ahn J; Choi HJ; You YK; Jang JW; Bae SH; Choi JY; Yoon SK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946835
[TBL] [Abstract][Full Text] [Related]
6. Mucosal-Associated Invariant T Cell Dysregulation Correlates With Conjugated Bilirubin Level in Chronic HBV Infection.
Liu Y; Zhu P; Wang W; Tan X; Liu C; Chen Y; Pei R; Cheng X; Wu M; Guo Q; Liang H; Liang Z; Liu J; Xu Y; Wu X; Weng X
Hepatology; 2021 May; 73(5):1671-1687. PubMed ID: 33080074
[TBL] [Abstract][Full Text] [Related]
7. Activated but impaired IFN-γ production of mucosal-associated invariant T cells in patients with hepatocellular carcinoma.
Huang W; Ye D; He W; He X; Shi X; Gao Y
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34789552
[TBL] [Abstract][Full Text] [Related]
8. Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy.
Jarvis EM; Collings S; Authier-Hall A; Dasyam N; Luey B; Nacey J; Painter GF; Delahunt B; Hermans IF; Weinkove R
Front Immunol; 2021; 12():748741. PubMed ID: 34737749
[TBL] [Abstract][Full Text] [Related]
9. Human liver CD8
Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
[TBL] [Abstract][Full Text] [Related]
10. TREM2
Tan J; Fan W; Liu T; Zhu B; Liu Y; Wang S; Wu J; Liu J; Zou F; Wei J; Liu L; Zhang X; Zhuang J; Wang Y; Lin H; Huang X; Chen S; Kuang M; Li J
J Hepatol; 2023 Jul; 79(1):126-140. PubMed ID: 36889359
[TBL] [Abstract][Full Text] [Related]
11. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
[TBL] [Abstract][Full Text] [Related]
12. CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy.
Qu J; Wu B; Chen L; Wen Z; Fang L; Zheng J; Shen Q; Heng J; Zhou J; Zhou J
J Exp Clin Cancer Res; 2024 May; 43(1):134. PubMed ID: 38698468
[TBL] [Abstract][Full Text] [Related]
13. Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions.
Healy K; Pavesi A; Parrot T; Sobkowiak MJ; Reinsbach SE; Davanian H; Tan AT; Aleman S; Sandberg JK; Bertoletti A; Sällberg Chen M
JHEP Rep; 2021 Aug; 3(4):100318. PubMed ID: 34377970
[TBL] [Abstract][Full Text] [Related]
14. Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma.
Melo AM; O'Brien AM; Phelan JJ; Kennedy SA; Wood NAW; Veerapen N; Besra GS; Clarke NE; Foley EK; Ravi A; MacCarthy F; O'Toole D; Ravi N; Reynolds JV; Conroy MJ; Hogan AE; O'Sullivan J; Dunne MR
Front Immunol; 2019; 10():1580. PubMed ID: 31354725
[TBL] [Abstract][Full Text] [Related]
15. Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation.
Bolte FJ; O'Keefe AC; Webb LM; Serti E; Rivera E; Liang TJ; Ghany M; Rehermann B
Gastroenterology; 2017 Nov; 153(5):1392-1403.e2. PubMed ID: 28780074
[TBL] [Abstract][Full Text] [Related]
16. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
17. Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization.
Li Y; Huang B; Jiang X; Chen W; Zhang J; Wei Y; Chen Y; Lian M; Bian Z; Miao Q; Peng Y; Fang J; Wang Q; Tang R; Gershwin ME; Ma X
Front Immunol; 2018; 9():1994. PubMed ID: 30233587
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.
Wan S; Zhao E; Kryczek I; Vatan L; Sadovskaya A; Ludema G; Simeone DM; Zou W; Welling TH
Gastroenterology; 2014 Dec; 147(6):1393-404. PubMed ID: 25181692
[TBL] [Abstract][Full Text] [Related]
19. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
[TBL] [Abstract][Full Text] [Related]
20. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.
Chen DP; Ning WR; Jiang ZZ; Peng ZP; Zhu LY; Zhuang SM; Kuang DM; Zheng L; Wu Y
J Hepatol; 2019 Aug; 71(2):333-343. PubMed ID: 31071366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
